BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7522936)

  • 21. [Interferons: physiology, pharmacology and pharmacotherapeutic perspectives].
    Billiau A
    J Pharmacol; 1983; 14 Suppl 3():105-16. PubMed ID: 6200731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon receptor expression regulates the antiproliferative effects of interferons on cancer cells and solid tumors.
    Wagner TC; Velichko S; Chesney SK; Biroc S; Harde D; Vogel D; Croze E
    Int J Cancer; 2004 Aug; 111(1):32-42. PubMed ID: 15185340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay.
    Schiller JH; Willson JK; Bittner G; Wolberg WH; Hawkins MJ; Borden EC
    J Interferon Res; 1986 Dec; 6(6):615-25. PubMed ID: 2437222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type III IFNs: new layers of complexity in innate antiviral immunity.
    Ank N; Paludan SR
    Biofactors; 2009; 35(1):82-7. PubMed ID: 19319850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Present state and perspective of cytokine research].
    Takaku F
    Hum Cell; 1993 Jun; 6(2):75-81. PubMed ID: 7692952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon modulates central nervous system function.
    Reyes-Vázquez C; Prieto-Gómez B; Dafny N
    Brain Res; 2012 Mar; 1442():76-89. PubMed ID: 22322149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interferons--research, effects and importance].
    Lodemann E
    Naturwissenschaften; 1984 Nov; 71(11):547-51. PubMed ID: 6084176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanisms of the antitumor effects interferons].
    Adam Z
    Vnitr Lek; 1994 Jan; 40(1):56-8. PubMed ID: 7511261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress toward therapeutic application of interferons, 1979-1983.
    Borden EC
    Cancer; 1984 Dec; 54(11 Suppl):2770-6. PubMed ID: 6208992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon treatment of human malignancies--a short review.
    Einhorn S; Strander H
    Med Oncol Tumor Pharmacother; 1993; 10(1-2):25-9. PubMed ID: 7505041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumour effect of interferons, cytostatic drugs and their combinations in subrenal capsule assay (SRCA).
    Kangas L; Cantell K; Grönroos M; Mäenpää J; Perilä M
    Ann Chir Gynaecol Suppl; 1985; 199():60-3. PubMed ID: 2415035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interferons, a class of cytokines with a large therapeutic activity range].
    Billard C
    Bull Cancer; 1993 Sep; 80(9):741-56. PubMed ID: 7515733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferons and the tumor cell.
    Strander H; Einhorn S
    Biotherapy; 1996; 8(3-4):213-8. PubMed ID: 8813333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of C1-inhibitor synthesis by interferons and other agents.
    Lappin D; Whaley K
    Behring Inst Mitt; 1989 Jul; (84):180-92. PubMed ID: 2478116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of interferon mediated anti-viral resistance.
    Clarke CJ; Trapani JA; Johnstone RW
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):117-30. PubMed ID: 12476793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferons (IFNs) and tumor necrosis factors (TNFs) in T cell-mediated immune responses against alloantigens. I. Influence on the activation of resting and antigen-primed T cells.
    Troppmair J; Auböck J; Niederwieser D; Schönitzer D; Huber C
    Immunobiology; 1988 Feb; 176(3):236-54. PubMed ID: 2452129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNAs in virus-induced tumorigenesis and IFN system.
    Fiorucci G; Chiantore MV; Mangino G; Romeo G
    Cytokine Growth Factor Rev; 2015 Apr; 26(2):183-94. PubMed ID: 25466647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy of cancer with interferon: lessons from tumor models and perspectives for clinical applications.
    Ferrantini M; Belardelli F
    Semin Cancer Biol; 2000 Apr; 10(2):145-57. PubMed ID: 10936064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon and malignant disease--how does it work and why doesn't it always?
    Grandér D; Einhorn S
    Acta Oncol; 1998; 37(4):331-8. PubMed ID: 9743454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferons (IFNs) are key cytokines in both innate and adaptive antiviral immune responses--and viruses counteract IFN action.
    Bonjardim CA
    Microbes Infect; 2005 Mar; 7(3):569-78. PubMed ID: 15792636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.